Recently, functional expression studies of de novo missense mutations underlying TRPM3-NDD, which include ophthalmological findings other than cataract, have been shown to increase basal channel activity leading to cellular calcium overload and enhanced response to PS activation—consistent with a deleterious gain-of-function effect(s) [51]. Here, TRPM3 is linked to Neurodevelopmental delay.